Regulation of Human Cytotoxic Responses by Complement: C3, C3b and C3d Preparations Enhance Human Allogeneic Cytotoxic Responses
- 1 January 1986
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 8 (4) , 529-541
- https://doi.org/10.3109/08923978609026504
Abstract
Complement components and complement breakdown products have been found to participate in the regulation of the immune response. In the present study we investigated the effect of C3 and its fragments, C3b, C3c and C3d on human allogeneic cell mediated lympholysis (CML). C3 and C3b at a concentration of 275 M .times. 10-9 and C3d at a concentration of 330 M .times. 10-9 enhanced human allogeneic CML by at least two fold. In contrast C3c did not affect CML responses. Both C3b and C3d had to be present at the initiation of the cultures in order to exert their effect. Similar doses of C3b and C3d did not affect the mixed lymphocyte responses (3H-thymidine uptake) while higher doses were clearly inhibitory. None of the preparations induced proliferative or cytotoxic responses in the absence of allogeneic stimulating cells. C3b and C3d added to the mixed lymphocyte cultures caused increased production of interleukin 2. We conclude that C3b and C3d facilitate allogeneic cytotoxic responses through increased production of interleukin 2.This publication has 20 references indexed in Scilit:
- The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytesEuropean Journal of Immunology, 1985
- Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferationMolecular Immunology, 1984
- Complement inhibits immune responses: C3 preparations inhibit the generation of human cytotoxic T lymphocytesEuropean Journal of Immunology, 1983
- Cytotoxic responses to alloantigens in systemic lupus erythematosusJournal of Clinical Immunology, 1981
- Large scale isolation of functionally active components of the human complement system.Journal of Biological Chemistry, 1981
- Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin.The Journal of Experimental Medicine, 1980
- Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factorInfection and Immunity, 1979
- Interaction of Soluble C3 Fragments with Guinea Pig Lymphocytes. Comparison of Effects of C3a, C3b, C3c, and C3d on Lymphokine Production and Lymphocyte ProliferationThe Journal of Immunology, 1976
- Stimulation of murine B lymphocytes by isolated C3b.The Journal of Experimental Medicine, 1975
- Lymphokine Production by C3b-Stimulated B CellsThe Journal of Immunology, 1975